What Is TB-500? A Research Overview

TB-500 is a frequently studied research peptide related to a naturally occurring protein called Thymosin Beta-4. This overview summarizes what it is and what research has examined — for laboratory reference only.

What is TB-500?

TB-500 is a synthetic peptide corresponding to an active region of Thymosin Beta-4 (Tβ4), a naturally occurring protein involved in cellular processes such as actin regulation. Because Tβ4 itself is large, research often uses the shorter TB-500 fragment. The name "TB-500" is used mainly in the research-material market for this fragment, whereas the primary scientific literature usually refers to thymosin β4 (Tβ4) itself — a distinction worth keeping in mind when reading the sources cited below.

What research has examined

Laboratory and animal-model studies of Thymosin Beta-4 / TB-500 have explored:

• Cell migration — Tβ4's role in actin binding and the movement of cells, a process relevant to tissue-repair research.¹
• Wound-model research — a classic study reported that adding Tβ4 increased reepithelialization by roughly 42% at 4 days and up to 61% at 7 days post-wounding in an animal model.²
• Angiogenesis — formation of new blood vessels; Tβ4 has been described as essential for coronary vessel development and as promoting neovascularization via the adult epicardium in cardiac models.³

As with all preclinical research, these findings describe controlled laboratory observations and are presented for scientific reference only.

The actin connection

The defining biochemical feature of Thymosin Beta-4 is that it is the major actin-sequestering molecule in many mammalian cells — it binds monomeric (G-)actin and helps regulate assembly of the actin cytoskeleton.¹ Because cytoskeletal remodeling underlies how cells move, investigators have studied Tβ4 (and the TB-500 fragment) in the context of cell migration, extracellular-matrix deposition, and the coordinated steps of experimental tissue repair. It is this mechanism — not a hormone-like receptor action — that most of the peptide's recovery-research literature is built around.

Cardiac and vascular research

A distinct branch of the literature examines Tβ4 in the heart. In developmental and injury models it has been described as essential for coronary vessel formation and as a paracrine signal that prompts epicardium-derived cells to migrate inward and contribute to new vasculature.³ Related work has paired Tβ4 with cardiac-reprogramming factors in repair-focused studies.⁴ Broader reviews frame Tβ4 as a multifunctional tissue-repair and regeneration peptide across several organ systems.⁵ These are animal- and cell-model findings reported by investigators — not clinical outcomes in humans.

TB-500 vs full-length Thymosin β4

"TB-500" typically refers to a synthetic fragment corresponding to the biologically active region of Tβ4, whereas "Thymosin β4" is the full 43-amino-acid protein. Much of the primary literature studies the full protein; researchers reference the shorter fragment largely for practical, laboratory-handling reasons. Supplied lyophilized and reconstituted with bacteriostatic water, it is handled like other research peptides; those assessing solution stability also consider a compound's half-life.

What the research does not establish

The TB-500 / Tβ4 record is predominantly preclinical. Controlled human clinical evidence is limited, and Renova makes no human-use, safety, or performance claims of any kind. The references below are provided so researchers can consult the primary sources directly and judge them on their own terms.

Often studied alongside BPC-157

TB-500 and BPC-157 are frequently referenced together in tissue-repair research — the basis for the combined "Wolverine" research blend. See our BPC-157 vs TB-500 comparison.

Handling and reconstitution in the lab

TB-500 is supplied as a lyophilized (freeze-dried) powder and reconstituted with bacteriostatic water before laboratory use; reconstituted vials are refrigerated (2–8°C). Because a synthetic fragment is easier to manufacture consistently and handle at scale than the full 43-residue protein, most research-material suppliers work with the TB-500 fragment — one practical reason it, rather than full-length Tβ4, appears across the catalog. As with any research peptide, reproducibility hinges on controlling the reconstituted concentration and the cold chain; our reconstitution guide and storage guide walk through the mg-to-mL math and handling, and researchers comparing compounds also weigh a peptide's half-life in solution. This describes laboratory handling of a research-only material — not directions for human or animal use.

Purity and verification

Every batch of Renova TB-500 ships with a published third-party COA reporting HPLC purity and labeled-vs-actual content. Confirm your lot with Verify Your Vial.

Explore TB-500 →

References

1. Goldstein AL, Hannappel E, Kleinman HK. Thymosin β4: actin-sequestering protein moonlights to repair injured tissues. Trends Mol Med. 2005;11(9):421–429. ↩ ↩²

2. Malinda KM, et al. Thymosin beta4 accelerates wound healing. J Invest Dermatol. 1999;113(3):364–368. PMID: 10469335. ↩

3. Smart N, et al. Thymosin beta-4 is essential for coronary vessel development and promotes neovascularization via adult epicardium. Ann N Y Acad Sci. 2007;1112:171–188. PMID: 17495252. ↩ ↩²

4. Srivastava D, et al. Cardiac repair with thymosin β4 and cardiac reprogramming factors. Ann N Y Acad Sci. 2012;1270:66–72. PMID: 23050819. ↩

5. Philp D, Kleinman HK. Animal studies with thymosin beta, a multifunctional tissue repair and regeneration peptide. Ann N Y Acad Sci. 2010;1194:81–86. PMID: 20536453. ↩